Search results
Gerhard Johannes Paul Domagk (German pronunciation: [ˈɡeːɐ̯haʁt ˈdoːmak] ⓘ; 30 October 1895 – 24 April 1964) was a German pathologist and bacteriologist. He is credited with the discovery of sulfonamidochrysoidine (KL730) as an antibiotic for which he received the 1939 Nobel Prize in Physiology or Medicine .
The Nobel Prize in Physiology or Medicine 1939 was awarded to Gerhard Domagk "for the discovery of the antibacterial effects of prontosil"
The supreme aim of chemotherapy is, in Domagk’s opinion, the cure and control of carcinoma and he was convinced that this will be, in the future, achieved. Domagk held honorary doctorates of the Universities of Bologna, Münster, Cordoba, Lima, Buenos Aires, and Giessen.
Gerhard Domagk was a German bacteriologist and pathologist who was awarded the 1939 Nobel Prize for Physiology or Medicine for his discovery (announced in 1932) of the antibacterial effects of Prontosil, the first of the sulfonamide drugs. Domagk earned a medical degree from the University of Kiel.
- The Editors of Encyclopaedia Britannica
Apr 12, 2022 · Encouraged by his success in destroying pathogens outside the body, the researcher began looking for ways to combat bacteria inside the body as well. He conducted intensive research based on the antibacterial properties of sulfonamide groups in azo dyestuffs.
Jun 10, 2024 · His first major success was the discovery of germanin, which was then the most effective drug against sleeping sickness. His prize-winning work was the discovery that the dye Prontosil was effective against streptococcal bacteria in mice.
People also ask
Who was Gerhard Domagk?
How did Domagk contribute to medicine?
What did Gerhard Domagk discover?
How did Domagk contribute to the development of antibiotics?
What did Domagk do for a living?
How did Dr Domagk become a doctor?
Mar 13, 2020 · Domagk’s pioneering research led to the development of Prontosil Rubrum, the first antibiotic drug to cure bacterial infections and the first of many sulfa drugs. Overview. In the 1920s and 1930s common bacterial infections ran rampant in Europe and the United States.
